本页面由Tiger Trade Technology Pte. Ltd.提供服务

1药网

8.10
+0.25503.25%
盘后8.150.0500+0.62%19:58 EST
成交量:12.74万
成交额:102.52万
市值:7,020.62万
市盈率:-7.14
高:8.19
开:7.74
低:7.74
收:7.85
52周最高:11.35
52周最低:2.48
股本:866.74万
流通股本:350.51万
量比:3.02
换手率:3.64%
股息:- -
股息率:- -
每股收益(TTM):-1.1341
每股收益(LYR):-1.0324
净资产收益率:-10.86%
总资产收益率:-0.21%
市净率:-0.71
市盈率(LYR):-7.85

数据加载中...

2025/08/29

SEC问询函

Form CORRESP - Correspondence
2025/08/29

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

SEC问询函

Form CORRESP - Correspondence
2025/08/06

SEC问询函

Form CORRESP - Correspondence
2025/04/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/02

SEC问询函

Form CORRESP - Correspondence
2023/07/17

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/31

SEC问询函

CORRESP [Cover] - Correspondence
2022/10/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/27

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/23

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/19

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]